A randomized study comparing full dose and half dose of rituximab in relapsing pemphigus patients.

Marwah Adly SalehNoha Adly Saleh

Published in: Dermatologic therapy (2020)

Keyphrases

end stage renal disease
multiple sclerosis
ejection fraction
newly diagnosed
chronic kidney disease
diffuse large b cell lymphoma
disease activity